Home
Site Search
Use small fonts Use medium fonts Use large fonts Email link to page

Resources

Related expertise

Canadian Life Science Law Blog Round-Up - June 2017

Published: 06/01/2017

By Cameron A. Mingay, Alison Hayman, A. Chandimal Nicholas, Steven Kennedy, Jonathan Sherman, Jacqueline Richards

In This Issue

  1. Health Canada Improvements to the Licensing of Cannabis Production under the ACMPR
  2. New Proposed Regulations Would Establish Mechanism to Import and Sell Unauthorized Drugs For an Urgent Public Need
  3. Health Canada Implements Mandatory Pesticide Testing of Cannabis
  4. Growing Pains: The emerging role of IP in selling Canadian cannabis

Health Canada Improvements to the Licensing of Cannabis Production under the ACMPR

By Jonathan Sherman

On May 26, 2017, Health Canada announced significant developments to the licensing process under the Access to Cannabis for Medical Purposes Regulations (ACMPR). As the medical cannabis industry continues to evolve, the Government of Canada has updated its licensing regime in order to streamline the process and enable increased production.

Read more about Health Canada Improvements to the Licensing of Cannabis Production under the ACMPR.

Top

New Proposed Regulations Would Establish Mechanism to Import and Sell Unauthorized Drugs For an Urgent Public Need

Health Canada has recently proposed amendments to the Food and Drug Regulations to allow the importation and sale of drugs for an urgent public health need.

Read more about Health Canada's recent proposed amendments to the Food and Drug Regulations.

Top

Health Canada Implements Mandatory Pesticide Testing of Cannabis

Health Canada has announced that it will require licensed cannabis producers to conduct mandatory testing of all cannabis products destined for sale for the presence of unauthorized pesticides.

Read about Health Canada's mandatory pesticide testing of cannabis.

Top

Growing Pains: The emerging role of IP in selling Canadian cannabis

By Alison Hayman

Licensed producers and others looking to enter Canada’s medical or recreational cannabis industry should be thinking about how they will distinguish their business, products and services from others, in what will undoubtedly become a crowded and competitive marketplace. Intellectual property protection available under Canadian and foreign laws should be an important part of that strategy.

Read more about the emerging role of IP in selling Canadian cannabis.

Top